Cancer Network Podcasts
MBCC: HER2-Positive Breast Cancer Demonstrates Heterogenous Outcomes
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:03:33
- Mais informações
Informações:
Sinopse
The discovery of human epidermal growth factor receptor 2 (HER2)-positive breast cancer subtypes is not yet complete, according to Mark D. Pegram, MD, who will be delivering a presentation on the different clinical outcomes of these subtypes at the Miami Breast Cancer Conference this week.
